Aim Immunotech Stock Total Asset
| 0A4Y Stock | 0.13 0.01 8.33% |
AIM ImmunoTech fundamentals help investors to digest information that contributes to AIM ImmunoTech's financial success or failures. It also enables traders to predict the movement of AIM Stock. The fundamental analysis module provides a way to measure AIM ImmunoTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AIM ImmunoTech stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 74.3 M | 78 M |
AIM | Total Asset |
AIM ImmunoTech Company Total Asset Analysis
AIM ImmunoTech's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current AIM ImmunoTech Total Asset | 78.0M |
Most of AIM ImmunoTech's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AIM ImmunoTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
AIM Total Assets
Total Assets |
|
At this time, AIM ImmunoTech's Total Assets are comparatively stable compared to the past year.
AIM Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AIM ImmunoTech's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AIM ImmunoTech could also be used in its relative valuation, which is a method of valuing AIM ImmunoTech by comparing valuation metrics of similar companies.AIM ImmunoTech is currently under evaluation in total asset category among its peers.
AIM Fundamentals
| Return On Equity | -1.88 | ||||
| Return On Asset | -0.84 | ||||
| Operating Margin | (128.26) % | ||||
| Current Valuation | 4.62 M | ||||
| Shares Owned By Insiders | 9.68 % | ||||
| Shares Owned By Institutions | 12.53 % | ||||
| Revenue | 190 K | ||||
| Gross Profit | 154 K | ||||
| EBITDA | (27.68 M) | ||||
| Net Income | (19.45 M) | ||||
| Book Value Per Share | 0.05 X | ||||
| Earnings Per Share | (0.40) X | ||||
| Number Of Employees | 26 | ||||
| Beta | -0.3 | ||||
| Retained Earnings | (361.1 M) |
About AIM ImmunoTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AIM ImmunoTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AIM ImmunoTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AIM ImmunoTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.